Role of DUSP1/MKP1 in tumorigenesis, tumor progression and therapy

Jiliang Shen1, Yaping Zhang2, Hong Yu1

  • 1Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, 310016, China.

Cancer Medicine
|May 27, 2016
PubMed

Insights

Dual-specificity phosphatase-1 (DUSP1) regulates cell signaling pathways and is implicated in cancer development and treatment. This review explores DUSP1

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Dual-specificity phosphatase-1 (DUSP1), also known as MKP1, dephosphorylates key signaling proteins like ERKs, p38 MAPKs, and JNKs.
  • DUSP1 plays critical roles in normal cellular processes such as proliferation, differentiation, and apoptosis.

Purpose of the Study:

  • To review the function and mechanisms of DUSP1 in cancer cells.
  • To explore the role of DUSP1 in various cancer treatment modalities.

Main Methods:

  • Studies utilizing gene knockout mice and gene silencing technology elucidated DUSP1's dephosphorylation mechanisms.
  • Analysis of DUSP1 expression patterns in human cancers and their correlation with patient prognosis.

Main Results:

  • Abnormal DUSP1 expression is observed in various human cancers, impacting tumor prognosis.
  • DUSP1 is involved in tumorigenesis, tumor progression, and response to chemotherapy, immunotherapy, and biotherapy.

Conclusions:

  • DUSP1 is a significant factor in cancer biology, influencing both disease progression and therapeutic outcomes.
  • Understanding DUSP1's role is crucial for developing novel cancer treatment strategies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.8K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K